Cisplatin-VP16 Alternating with Cyclophosphamide-Epirubicin versus Cyclophosphamide-Epirubicin-Vincristine in Small Cell Lung Cancer
Author:
Publisher
Informa UK Limited
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883
Reference12 articles.
1. Ihde D. Current status of therapy for small cell carcinoma of the lung. Cancer 1984; 54: 2722–2728.
2. Seifter EJ, Ihde D. Therapy of small cell lung cancer: A perspective on two decades of clinical research. Sem Oncol 1988; 15: 278–299.
3. Goldie JH, Golman AJ. The genetic origin of drug resistance in neoplasms: implication for systemic therapy. Cancer Res 1984; 44: 3653.
4. Johnson DH, De Leo M, Hande K, Wolff S, Hainsworth J, Greco A. High dose induction chemotherapy with cyclophosphamide, etoposide and cisplatin for extensive stage small cell lung cancer. J Clin Oncol 1987; 5: 703–709.
5. Livingston RB. Current chemotherapy of small cell lung cancer. Chest 1986; 89: 2585–2635.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer;Cochrane Database of Systematic Reviews;2015-08-02
2. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer;Cochrane Database of Systematic Reviews;2008-10-08
3. A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis;Lung Cancer;2000-10
4. Standard combination versus alternating chemotherapy in small cell lung cancer;Lung Cancer;1999-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3